131 related articles for article (PubMed ID: 14642155)
1. The effect of arsenic trioxide on QT interval prolongation during APL therapy.
Zhou J; Meng R; Li X; Lu C; Fan S; Yang B
Chin Med J (Engl); 2003 Nov; 116(11):1764-6. PubMed ID: 14642155
[TBL] [Abstract][Full Text] [Related]
2. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
3. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.
Mumford JL; Wu K; Xia Y; Kwok R; Yang Z; Foster J; Sanders WE
Environ Health Perspect; 2007 May; 115(5):690-4. PubMed ID: 17520054
[TBL] [Abstract][Full Text] [Related]
4. Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia.
Sun Y; Wang L; Que Y; Zhu H; Yang X; Li D
Int J Cardiol; 2020 May; 306():163-167. PubMed ID: 31761398
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].
Shen JC; Liu KY; Jiang B; Lu XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):359-61. PubMed ID: 15308017
[TBL] [Abstract][Full Text] [Related]
6. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
[TBL] [Abstract][Full Text] [Related]
8. QT prolongation: a case of arsenical pericardial and pleural effusion.
Vizzardi E; Zanini G; Antonioli E; D'Aloia A; Raddino R; Cas LD
Cardiovasc Toxicol; 2008 Mar; 8(1):41-4. PubMed ID: 18084726
[TBL] [Abstract][Full Text] [Related]
9. Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells.
Jiang G; Bi K; Tang T; Zhang Y; Ren H; Jiang F; Ren Q; Zhen G; Liu C; Peng J; Guo G; Liu X; Tian Z
Chin Med J (Engl); 2003 Nov; 116(11):1639-43. PubMed ID: 14642127
[TBL] [Abstract][Full Text] [Related]
10. Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in Guinea pig.
Sun HL; Chu WF; Dong DL; Liu Y; Bai YL; Wang XH; Zhou J; Yang BF
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):381-8. PubMed ID: 16623862
[TBL] [Abstract][Full Text] [Related]
11. QT dispersion in uncomplicated human obesity.
Girola A; Enrini R; Garbetta F; Tufano A; Caviezel F
Obes Res; 2001 Feb; 9(2):71-7. PubMed ID: 11316349
[TBL] [Abstract][Full Text] [Related]
12. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.
Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U
Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415
[TBL] [Abstract][Full Text] [Related]
13. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women.
Bakiner O; Ertorer ME; Haydardedeoglu FE; Bozkirli E; Tutuncu NB; Demirag NG
Med Princ Pract; 2008; 17(5):390-4. PubMed ID: 18685279
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of QT interval in patients treated with psychotropic drugs.
Novotny T; Florianova A; Ceskova E; Weislamplova M; Palensky V; Tomanova J; Sisakova M; Toman O; Spinar J
Int J Cardiol; 2007 May; 117(3):329-32. PubMed ID: 16863665
[TBL] [Abstract][Full Text] [Related]
15. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
Douer D; Tallman MS
J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
[TBL] [Abstract][Full Text] [Related]
17. QTc abnormalities in deliberate self-poisoning with moclobemide.
Downes MA; Whyte IM; Isbister GK
Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
[TBL] [Abstract][Full Text] [Related]
18. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
Corović N; Duraković Z; Misigoj-Duraković M
Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
[TBL] [Abstract][Full Text] [Related]
19. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
Au WY; Kumana CR; Lam CW; Cheng VC; Shek TW; Chan EY; Liu R; Kwong YL
Leuk Res; 2007 Jan; 31(1):105-8. PubMed ID: 16725199
[TBL] [Abstract][Full Text] [Related]
20. QT interval analysis in patients with chronic liver disease: a prospective study.
Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
